|
|
|
|
|
|
|
|
|
|
We hope our readers had a wonderful weekend.
COVID-19 Data Update:
Yesterday, R(t) for the Greater Houston Area was 0.59. Any number above 1.0 indicates the virus continues to spread in our community. It is important to remember that the R-value will fluctuate day-to-day due to normal variation in inputs. This is why we also look at the weekly averages to get a sense of the direction of virus growth in our community. Last week, the average R(t) was 0.61.
Yesterday, 508 people tested positive for COVID-19 in the Greater Houston Area. Last week, on average, there were 672 new cases/day. Yesterday, TMC admitted 116 new COVID-19 patients/day in TMC hospital institutions. Last week, on average, TMC admitted 121 new patients/day.
COVID-19 Vaccination Update:
3,000,806 doses have been administered by TMC institutions. Over the last week, an average of 500 doses per day have been administered. 1,375,674 have been fully vaccinated. |
|
|
|
|
| |
|
|
|
|
|
|
'Drug Factory' Implants Eliminate Ovarian, Colorectal Cancer in Mice
|
|
|
Rice University bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days with a treatment that could be ready for human clinical trials later this year.
To read more, click here.
|
|
|
|
|
|
|
|
|
TMC | NEWS
|
|
TMC's New Restaurant, III By Wolfgang Puck, is Now Open
|
|
|
TMC’s new restaurant, III by Wolfgang Puck, is now open for lunch, happy hour, and dinner Monday through Friday. Located on the 6th floor of John P. McGovern Texas Medical Center Commons, III by Wolfgang Puck combines innovative cuisine with approachable dining in a relaxed and welcoming setting. The seasonal menus feature Wolfgang’s signature globally inspired comfort food using the freshest ingredients available from local farmers and purveyors.
For more information or to make a reservation, please click here, or call 713.749.0400.
|
|
|
|
|
|
|
|
|
MEMORIAL HERMANN HOSPITAL | NEWS
|
|
Memorial Hermann Updates Visitor Policy
|
|
|
Memorial Hermann remains committed to providing a safe environment for their patients and their loved ones, as well as for their employees, physicians, and other members of their workforce. As the number of new COVID-19 cases continues to decline throughout our community and across Memorial Hermann, the health system is pleased to announce the following modifications to its visitor policy.
To read more about the policy, click here.
|
|
|
|
|
|
|
|
|
MD ANDERSON CANCER CENTER | NEWS
|
|
|
|
Study Defines Stem Cell Groups That Drive Myelodysplastic Syndromes, Finds Potential Targeted Therapy Option
|
Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells. Their findings, which could have significant benefits for patients with disease progression, were published today in Nature Medicine.
This research, which spans preclinical and clinical studies, represents the largest analysis to date of MDS patient samples. If further validated in larger clinical trials, the data suggests that the stem cell profiles of MDS could be considered as a biomarker for guiding the design or choice of secondary lines of therapy. Importantly, these findings indicate that treatment with venetoclax induces the death of stem cells in one of the MDS groups.
To read more, click here.
|
|
|
|
|
|
|
|
|
|
|
|
